Literature DB >> 9612887

Parametric likelihoods for multiple non-fatal competing risks and death.

Y Shen1, P F Thall.   

Abstract

Clinical trials of fatal diseases often focus on one or more non-fatal events, in addition to survival, both to characterize morbidity and to improve survival estimates. Three statistical complications are that the time to each non-fatal event and subsequent residual survival may be either positively or negatively associated, the times to death with or without an antecedent event often have very different distributions, and death may censor some of the non-fatal event times. Consequently, the overall survival time distribution is a mixture of the distributions corresponding to the possible antecedent non-fatal events. These conditions violate the usual assumptions underlying many statistical methods for analysing multivariate time-to-event data. In this paper, we consider a general parametric model for multiple non-fatal competing risks and death. The model accounts for positive or negative association between the time of each non-fatal event and subsequent survival while accommodating covariates and the usual administrative censoring. Each event time distribution is specified marginally by a three-parameter generalized odds rate model, and the time of each non-fatal event and subsequent residual survival are combined under a bivariate generalized von Morgenstern distribution. The approach is illustrated by application to two data sets from clinical trials in colon cancer and acute leukaemia.

Entities:  

Mesh:

Year:  1998        PMID: 9612887     DOI: 10.1002/(sici)1097-0258(19980515)17:9<999::aid-sim785>3.0.co;2-3

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  4 in total

1.  A new statistical method for dose-finding based on efficacy and toxicity in early phase clinical trials.

Authors:  P F Thall; E H Estey; H G Sung
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

2.  Evaluating Joint Effects of Induction-Salvage Treatment Regimes on Overall Survival in Acute Leukemia.

Authors:  Abdus S Wahed; Peter F Thall
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2013-01       Impact factor: 1.864

3.  Bayesian gamma frailty models for survival data with semi-competing risks and treatment switching.

Authors:  Yuanye Zhang; Ming-Hui Chen; Joseph G Ibrahim; Donglin Zeng; Qingxia Chen; Zhiying Pan; Xiaodong Xue
Journal:  Lifetime Data Anal       Date:  2013-03-30       Impact factor: 1.588

4.  Beyond Composite Endpoints Analysis: Semicompeting Risks as an Underutilized Framework for Cancer Research.

Authors:  Ina Jazić; Deborah Schrag; Daniel J Sargent; Sebastien Haneuse
Journal:  J Natl Cancer Inst       Date:  2016-07-05       Impact factor: 13.506

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.